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ABStrAct
Malaria remains an important public health issue all over the world. Among 5 Plasmodium species invasive 
to humans, Plasmodium knowlesi has been identified most recently. It is sometimes difficult to differentiate  
this species from P. malariae with the use of microscopic examination. However, P. knowlesi infection 
may be associated with rapidly increasing parasitaemia and severe clinical course with the risk of death.
Samples from Polish travellers returning from areas where simian malaria is endemic were examined with 
the use of polymerase chain reaction (PCR). The small subunit of ribosomal RNA (SSU rRNA) genes was 
subjected to analysis using nested PCR reaction.
No positive results of P. knowlesi were obtained. Due to morphological similarities to P. malariae, potentially 
severe clinical course of infection and P. knowlesi endemic regions being a common tourist destination, dia-
gnostic and clinical vigilance is necessary, including molecular methods use for precise parasite identification.
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INTRODUCTION
Malaria still remains a serious public health challenge 
in the tropics. Despite governmental and non-governmental 
organisations efforts to decrease the number of malaria 
cases in the world, still almost 200 million symptomatic 
infections are diagnosed yearly with estimated 584,000 
deaths (as at 2014) [1]. There are over than 200 species 
of Plasmodium that infect different hosts [2]. Only 4 spe-
cies, namely Plasmodium falciparum, P. vivax, P. malariae, 
and P. ovale are well-known infectious agents that cause 
this disease in humans. The fifth species — P. knowlesi — 
a simian malaria parasite species commonly found in long-
tailed and pigtailed macaques (Macaca fascicularis and 
Macaca nemestrina, respectively) is the only malaria para-
site affecting primates with a 24-h erythrocytic cycle [3, 4]. 
P. knowlesi is transmitted by Anopheles leucosphyrus group 
[5]. Simian malaria parasites were first reported in Malayan 
monkeys by Daniels in 1908 [6]. In 1965 the first natural 
infection in human was reported in a man from the United 
States who was infected in the jungles of Pahang, Malaysia 
[7]. In 2004, Singh et al. [8] reported the presence of a 
large number of P. knowlesi cases in Sarawak, a state in 
Malaysian Borneo. Human infections with P. knowlesi, a 
simian malaria parasite, are more common than previously 
thought [9]. P. knowlesi malaria appears to be the most 
common malaria species in Malaysian Borneo and is also 
widely distributed on the Malaysian mainland. Moreover, 
locally transmitted cases of simian malaria in humans have 
been reported in Thailand, the Philippines, Vietnam, Singa-
pore, Myanmar, Indonesian Borneo, Brunei, Cambodia and 
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Andaman and Nicobar Islands of India. Two cases have been 
reported from non-endemic countries in Asia (Japan and 
Taiwan) in people with a history of travel to Malaysia and 
the Philippines. Twelve cases were imported to their home 
countries by travellers from other continents: 2 from the 
United States, 2 from the Netherlands, 2 from Germany, and 
1 each from Spain, France, Sweden, Finland, Australia, and 
New Zealand. In most cases, the infection was associated 
with a trip to or near forested areas [3, 10]. 
The “gold standard” for the identification of Plasmodium 
species is microscopic examination because it is relatively rapid 
and inexpensive. However, because of similarity of P. knowlesi 
and P. falciparum in the early trophozoite stage and with 
P. malariae in the late and mature trophozoites, gametocytes 
and schizonts, large numbers of false negative results is ob-
served [9, 10]. The high rate of misdiagnosis of P. knowlesi in-
fection as P. falciparum and P. malariae using light microscopy 
in non-endemic countries should lead to molecular diagnostic 
techniques [10]. Rapid diagnostic tests are becoming an in-
creasingly popular method for diagnosing malaria, particularly 
by medical laboratory technologists in non-malaria endemic 
countries, who are not experienced in identifying malaria par-
asites by microscopy [11, 12]. It is possible that the low para-
sitaemia may have been a contributing factor to the inability 
of the rapid diagnostic test to detect simian malaria, because 
these tests are not as sensitive as light microscopy [13].
The aim of the present study was retrospective identifica-
tion of Plasmodium knowlesi species using polymerase chain 
reaction (PCR) in diagnostic specimens, in Polish travellers 
with malaria infection, returned from areas where simian ma-
laria is endemic or whose history of travelling was not known. 
MATERIALS AND METHODS
A retrospective study was performed on blood samples 
from patients treated at the University Centre for Maritime 
and Tropical Medicine in Gdynia during the period 1995– 
–2013. Routine laboratory diagnosis (thick and thin Giemsa 
stained blood smears) was performed at the Department 
of Tropical Parasitology, Institute of Maritime and Tropical 
Medicine, Medical University of Gdansk, Poland. 
DNA ExTRACTION
DNA extraction from collected blood samples was per-
formed using a Blood Mini Kit (A&A Biotechnology, Poland), 
according to the manufacturer’s instructions. The PCR tem-
plates were stored at –20°C.
SpECIfIC DETECTION Of Plasmodium SPecIeS 
by NESTED pCR
The small subunit of ribosomal RNA (SSU rRNA) genes 
was subjected to analysis using nested PCR reaction. The 
first step was performed using the Plasmodium genus spe-
cific primers rPLU1 and RPLU5 [14]. The PCR amplification 
was performed in a 50 µL reaction mixture, which contained 
5 µL 10 × Reaction Buffer for RUN (A&A Biotechnology, Po-
land), 0.25 mM of each dNTP (Fermentas, Lithuania), 0.2 µM 
of each primer (Metabion, Germany), 1 U of RUN polymerase 
(A&A Biotechnology, Poland), and 1 µL of DNA template. The 
amplification conditions were as follows: 95oC for 5 min, 25 
cycles at 94oC for 1 min, 58oC for 2 min, 72oC for 2 min, 
followed by a final extension for 5 min at 72oC. The second 
step of PCR reactions was performed using primers Pmk8 
and Pmkr9 (specific to P. knowlesi), FAL1, FAL2 (specific to 
P. falciparum), VIV1, VIV2 (specific to P. vivax), MAL1, MAL2 
specific to P. malariae), OVA1, OVA2 (specific to P. ovale) 
[4, 14] in a 25 µL reaction volume containing 2,5 µL 10 × 
Reaction Buffer for RUN (A&A Biotechnology, Poland), 0.25 
mM of each dNTP (Fermentas, Lithuania), 0.2 µM of each 
primer (Metabion, Germany), 1 U of RUN polymerase (A&A 
Biotechnology, Poland), and 1 µL of DNA template. The PCR 
conditions were the same as described in the first round 
except that the number of cycles was 35. All PCR experiment 
were performed with the use of positive control (DNA isolat-
ed from infected patients) in case of P. falciparum, P. vivax, 
P. malariae and P. ovale control and a plasmid containing 
synthetic fragment of P. knowlesi sequence prepared by 
laboratory (DNA-Gdansk, Poland) and double distilled wa-
ter instead of a DNA template as a negative control. The 
PCR amplifications were run in a GeneAmp PCR System 
9700 Thermal Cycler (Applied Biosystems, USA). The PCR 
products were analysed using a Gel Doc-It Imaging System 
(UVP, USA) after electrophoresis on a 2% gel agarose, which 
was stained with Midori Green DNA Stain (Nippon Genetics 
Europe GmbH, Germany).
RESULTS
A retrospective study was performed on blood samples 
from 9 patients. No cases of P. knowlesi were diagnosed 
in the samples included into the study, while P. vivax, 
P. malariae and P. falciparum were detected (Table 1).
DISCUSSION
International travel, both for recreational and business 
purposes, has been rapidly increasing for last few decades. 
In the 1960s only 75 million people travelled abroad every 
year, while in 2000 this number reached 175 million [15]. 
Destinations include all parts of the world, including tropi-
cal regions where malaria and other tropical diseases are 
endemic. A rise in the number of trips to tropical countries 
is associated with increased risk of importing rare parasitic 
diseases to Europe. 
There is a growing interest in travelling among Polish 
citizens, including journeys to exotic off the beaten track 
or dangerous destinations. Moreover, there is a significant 
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Table 1. Malaria infection in Polish travellers returning from endemic areas of simian malaria diagnosed in the Department of Tropical 
Parasitology Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Poland 
Patient Year Blood smear Polymerase chain 
reaction 
Destination
1 1995 P. vivax, single trophozoites P. vivax Oceania + ?
2 1996 P. vivax, early trophozoites (rings), mature trophozoites, 
schizonts
P. vivax Papua New Guinea + ?
3 1996 Plasmodium sp., P. vivax? single mature trophozoites P. vivax Southeast Asia
4 1996 P. vivax, rings, mature trophozoites, gametocytes P. vivax Southeast Asia
5 1999 Negative P. malariae ?
6 2001 P. vivax, gametocytes P. vivax Indonesia
7 2001 P. falciparum, rings P. falciparum ?
8 2002 P. vivax, rings, mature trophozoites P. vivax Southeast Asia
9 2013 P. vivax, gametocytes P. vivax ?
number of missionaries who travel to several geographic 
locations worldwide and also contract employees working 
overseas. In 2012, 25,032,708 tourist arrivals were regis-
tered in Malaysia. Most of them were from Asia, especially 
from Singapore, Thailand, Indonesia, Brunei, and China. In 
the same year, Tourism Malaysia reported an increase in 
the number of travellers: 1,002,067 from Europe (also from 
Poland), 327,065 from the United States and Canada, and 
573,674 from New Zealand and Australia [15]. 
In Poland, approx. 20 to 50 imported cases of malaria 
are diagnosed yearly [16–18], and the number of report-
ed malaria cases remains low compared to countries of 
Western Europe. 30% of them, that is about 10 persons 
per year, are admitted to the University Centre for Maritime 
and Tropical Medicine in Gdynia [own study, unpublished 
data]. Among all malaria patients diagnosed and treated 
in Gdynia in 1984–1994, 16.84% were travellers returned 
from Asia [17]. In the Department and Clinic of Tropical 
and Parasitic Diseases, Medical University of Poznan in the 
years 2001–2013 this number reached 7.1%, while in the 
Department of Infectious Diseases and Hepatology, Pomer-
anian Medical University in Szczecin in the years 2010 and 
2011 it was 27.3% [19]. It can be assumed that some of 
these patients might have returned from region endemic 
for simian malaria and thus the prevalence of P. knowlesi 
in humans may be underestimated [9]. 
Malaria mortality rates vary between different countries. 
In the United Kingdom case fatality rate (in P. falciparum 
infections) is 1% and this value is similar in most developed 
countries [20]. In Poland case fatality rate in the year 2004 
was 3.4%, while in 2008 it was 4.3% [16]. These differences 
can be explained by lack of clinical experience in malaria 
treatment (due to a low number of imported malaria cases 
in Poland) as well as non-compliance with antimalarial pro-
phylaxis among Polish travellers. 
Treatment in cases of Plasmodium infection mainly 
depends on the patient’s condition, the species of Plas-
modium and the potential drug resistance. P. falciparum 
is considered the most dangerous species, requiring in-
tensive therapeutic measures from the treating physi-
cian. There are also reports on severe course of P. vivax 
infections, sometimes inappropriately called “benign” 
[21], such cases have also been observed in the Clinic of 
Tropical and Parasitic Diseases Institute of Maritime and 
Tropical Medicine, Medical University of Gdansk, Poland. 
Plasmodium ovale and P. malariae infections usually have 
an uncomplicated course and the patient’s condition is 
usually stable. 
The mature trophozoites, schizonts and mature gameto-
cytes of the described parasite P. knowlesi are practically 
indistinguishable from P. malariae in microscopic examina-
tion, therefore, misidentification of the parasite may give 
the treating physician a false sense of security, whereas 
P. knowlesi infection has a course similar to falciparum 
malaria and may result in sudden deterioration of patient’s 
condition and multi-organ failure [22]. Numerous reports on 
the difficulties in microscopic distinguishing of P. knowlesi 
from P. falciparum or P. malariae and on the consequences 
of misidentification exist in the literature [12, 23–25]. It is 
believed that microscopic examination without molecular 
confirmation has limited reliability e.g. in distinguishing 
between P. knowlesi/vivax/falciparum which leads to inap-
propriate treatment choices such as administering chloro-
quine in falciparum malaria or not prescribing primaquine 
in P. vivax infection. In the areas endemic for P. knowlesi, 
treatment unification for all malaria patients regardless of 
the parasite’s species has been advocated, along with the 
use of molecular techniques of species identification [26]. In 
non-endemic areas, patients returning from South-East Asia 
have been reported to be infected with P. knowlesi. Compli-
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cations typical for falciparum malaria, such as renal insuf-
ficiency, may occur even at low parasitaemia. In a German 
patient, renal failure was observed at parasitaemia of 0.2%. 
A 55-year-old woman with fever, nausea and vomiting 
10 days after a holiday in Thailand, presented acute kidney 
injury and elevated procalcitonine level. In stained thin and 
thick blood films, plasmodia resembling P. malariae were 
present with 0.2% trophozoite parasitaemia and numer-
ous gametocytes. With a diagnosis of malaria and acute 
renal failure, the patient was referred to the Tropical and 
Infectious Diseases Service. Monoinfection of P. knowlesi 
was confirmed by 3 techniques: PCR protocols based on 
18sRNA, mitochondrial DNA, the linker region of dihydrofo-
late reductase and thymidylate synthase. Intravenous treat-
ment with artesunate (2.4 mg/kg) was started and switched 
to oral treatment with artemether/lumefantrine. The patient 
recovered promptly with no sign of renal insufficiency [25].
No simian malaria cases were detected in our study. 
The majority of the patients in Poland were infected with the 
most severe P. falciparum species [17–19]. In patients with 
suspected or confirmed malaria, it is important to collect 
their epidemiological history for further diagnostics and par-
asite species identification in order to administer adequate 
treatment. It is crucial to identify P. knowlesi infections, 
especially in the late stage when the parasites resemble 
P. malariae, because P. knowlesi infections can sometimes 
be associated with complications and may be fatal. 
In Poland malaria is diagnosed most often with the 
use of microscopic examinations of blood films and rapid 
immunochromatographic tests. In low parasitaemia cases 
microscopic examinations may not be enough to identify 
the parasite species in mixed infections [27] and due to 
morphological similarities of P. knowlesi to P. falciparum 
and P. malariae adequate diagnosis is crucial for treatment 
selection and patient outcome. It has been suggested, that 
Plasmodium species identification is important not only for 
treatment modification in case of two species capable to 
develop hypnozoites (P. vivax, P. ovale), but also because 
of potentially severe clinical course of P. knowlesi malaria. 
Asexual stages of P. knowlesi are difficult to differentiate 
from P. malariae. The latter species however is not associ-
ated with high parasitaemia and results in uncomplicated 
malaria only. Thus in cases of malaria initially suspected as 
P. malariae, and with the epidemiological history pointing to 
the risk for simian malaria, potentially severe clinical course 
of infection should be considered and appropriate measures 
introduced, including patient monitoring and implementing 
proper medical care. For detailed assessment of aetiologi-
cal agent, parasite species identification is necessary and 
for this purpose molecular techniques are very useful and 
usually available in research units [28]. 
CONCLUSIONS
Physicians should be aware that simian malaria infec-
tion is an important differential diagnosis in febrile travellers 
with a recent travel history to Southeast Asia, who tested 
negative with rapid diagnostic tests or blood smears. 
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